A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations

Paula Martínez1, Raúl Sánchez-Vázquez1, Iole Ferrara-Romeo1

  • 1Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.

Plos Genetics
|June 21, 2022
PubMed

Insights

A new mouse model carrying a POT1 mutation (POT1R117C) develops angiosarcomas, mirroring human cancers. This model reveals POT1 mutations cause longer telomeres and dominant-negative effects, aiding cancer research.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Mutations in the shelterin protein POT1 are implicated in various cancers.
  • Existing research lacks suitable animal models to study POT1-related tumorigenesis.

Purpose of the Study:

  • To generate and characterize a mouse model for the human POT1R117C mutation.
  • To investigate the molecular mechanisms of POT1 mutant proteins in cancer development.

Main Methods:

  • Generated a knock-in mouse model (Pot1a+/ki) for the human POT1R117C mutation.
  • Analyzed telomere length in mouse embryonic fibroblasts (MEFs) and tissues.
  • Utilized complementation assays to assess POT1a pR117C effects.
  • Examined tumor incidence and telomere length in tumor cells.

Main Results:

  • Pot1a+/ki mice and MEFs exhibit significantly longer telomeres compared to wild-type.
  • Longer telomeres in MEFs are telomerase-dependent.
  • POT1a pR117C demonstrates dominant-negative effects at telomeres.
  • Pot1a+/ki mice develop a high incidence of angiosarcomas, including cardiac angiosarcomas, with abnormally long telomeres.

Conclusions:

  • The Pot1a+/R117C mouse model accurately recapitulates human POT1-mutated cancers.
  • This model provides a valuable tool for studying the pathobiology of POT1-driven human cancers.